ARTICLE | Company News
Corvas news
May 17, 1993 7:00 AM UTC
Corvas International Inc. (CVAS) Corvas International Inc. (CVAS) has received a $500,000 Phase II SBIR grant to continue the development of small protein inhibitors of coagulation. CVAS will evaluat...